Source: PharmaTimes

STIVARGA: Bayer's Stivarga wins NICE approval for GIST

Bayer's Stivarga has been recommended by the National Institute for Health and Care Excellence as a treatment for some patients with gastrointestinal stromal tumours (GIST).

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



STIVARGA's headquarters is in Whippany, New Jersey. STIVARGA has a revenue of $10M, and 10 employees.